Mathes Company Inc. Sells 1,275 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mathes Company Inc. trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,440 shares of the exchange traded fund’s stock after selling 1,275 shares during the period. Mathes Company Inc.’s holdings in SPDR S&P Biotech ETF were worth $875,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of XBI. Avoro Capital Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund grew its stake in SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after acquiring an additional 730,000 shares in the last quarter. Mirae Asset Securities USA Inc. bought a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at $55,626,000. Jane Street Group LLC lifted its stake in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Finally, Baymount Management LP bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $34,160,000.

SPDR S&P Biotech ETF Trading Down 0.1 %

NYSEARCA:XBI opened at $100.81 on Thursday. The company has a market capitalization of $7.68 billion, a P/E ratio of 11.47 and a beta of 1.11. The business’s 50-day moving average is $98.78 and its 200 day moving average is $93.87. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.